Aller au contenu

Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.

Nom du journal : Mol Cancer

Année : 2024

Volume : 23

Page de départ : 37

Auteurs: Sun, CM, Toulmonde, M, Spalato-Ceruso, M, Peyraud, F, Bessede, A, Kind, M & al,